| For: | Kreidl E, Öztürk D, Metzner T, Berger W, Grusch M. Activins and follistatins: Emerging roles in liver physiology and cancer. World J Hepatol 2009; 1(1): 17-27 [PMID: 21160961 DOI: 10.4254/wjh.v1.i1.17] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v1/i1/17.htm |
| Number | Citing Articles |
| 1 |
Ousseynou Sarr, Katherine E. Mathers, Christina Vanderboor, Kristina Wiggers, Aditya Devgan, Daniel B. Hardy, Lin Zhao, Timothy R. H. Regnault. Sex-specific alterations in hepatic cholesterol metabolism in low birth weight adult guinea pigs. Pediatric Research 2022; 91(5) doi: 10.1038/s41390-021-01491-w
|
| 2 |
Qinye Liu, Hui Shen, Xinglun Dang, Mike Zhongyu He, Yizhou Wei, Yingyun Shi, Xiaoyu Wei, Fen Chen, Di Han, Chengyong Liu, Jia Hu, Weina Liu. Genome-wide association study of myopia progression in Chinese adolescents and application of polygenic risk score prediction. Frontiers in Chemistry 2026; 14 doi: 10.3389/fchem.2026.1778732
|
| 3 |
C. Fournier, R. Rizzoli, K. Bouzakri, P. Ammann. Selective protein depletion impairs bone growth and causes liver fatty infiltration in female rats: prevention by Spirulina alga. Osteoporosis International 2016; 27(11) doi: 10.1007/s00198-016-3666-8
|
| 4 |
Emine Sahin, Julia Münzker, Michael Grusch. Encyclopedia of Cancer. 2014; doi: 10.1007/978-3-662-46875-3_7169
|
| 5 |
Dorota Skrzypczak, Marzena Skrzypczak-Zielińska, Alicja Ewa Ratajczak, Aleksandra Szymczak-Tomczak, Piotr Eder, Ryszard Słomski, Agnieszka Dobrowolska, Iwona Krela-Kaźmierczak. Myostatin and Follistatin—New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications. Biomedicines 2021; 9(10) doi: 10.3390/biomedicines9101301
|
| 6 |
Fen-Yu Tseng, Yen-Ting Chen, Yu-Chao Chi, Pei-Lung Chen, Wei-Shiung Yang. Serum Levels of Follistatin Are Positively Associated With Serum-Free Thyroxine Levels in Patients With Hyperthyroidism or Euthyroidism. Medicine 2016; 95(5) doi: 10.1097/MD.0000000000002661
|
| 7 |
Shifeng Su, Amanda B. Parris, Gail Grossman, James L. Mohler, Zengjun Wang, Elizabeth M. Wilson. Up‐Regulation of Follistatin‐Like 1 By the Androgen Receptor and Melanoma Antigen‐A11 in Prostate Cancer. The Prostate 2017; 77(5) doi: 10.1002/pros.23288
|
| 8 |
Silvia Iori, Caterina D'Onofrio, Nihay Laham-Karam, Isidore Mushimiyimana, Lorena Lucatello, Ludovica Montanucci, Rosa Maria Lopparelli, Federico Bonsembiante, Francesca Capolongo, Marianna Pauletto, Mauro Dacasto, Mery Giantin. Generation and characterization of cytochrome P450 3A74 CRISPR/Cas9 knockout bovine foetal hepatocyte cell line (BFH12). Biochemical Pharmacology 2024; 224 doi: 10.1016/j.bcp.2024.116231
|
| 9 |
Jun-Jie Zhang, Yi-Fan Chen, Lei Shi, Yi-Tong Wang, Xiao-Yu Zhao, Rong-Yan Zhou, Hui Chen, Hua-Ge Liu, Zhong-Hua Ning, De-He Wang. Genome-wide association analysis of eggshell pore traits based on whole genome resequencing. Frontiers in Animal Science 2024; 5 doi: 10.3389/fanim.2024.1469859
|
| 10 |
Joohyun Park, Fuzheng Guo, Jong Eun Lee, So Yeong Cheon. Hepatokines and stellakines in liver and neurological diseases: The liver-brain axis. Experimental Neurology 2026; 404 doi: 10.1016/j.expneurol.2026.115899
|
| 11 |
Stergios A. Polyzos, Jannis Kountouras, Athanasios D. Anastasilakis, Georgios Α. Triantafyllou, Christos S. Mantzoros. Activin A and follistatin in patients with nonalcoholic fatty liver disease. Metabolism 2016; 65(10) doi: 10.1016/j.metabol.2016.07.009
|
| 12 |
Hongjun Zhang, Baoling Ju, Ying Nie, Baohui Song, Yuanhong Xu, Ping Gao. Adenovirus‑mediated knockdown of activin A receptor type�2A attenuates immune‑induced hepatic fibrosis in mice and inhibits interleukin‑17‑induced activation of primary hepatic stellate cells. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3600
|
| 13 |
Wei Song, Daojun Cheng, Shangyu Hong, Benoit Sappe, Yanhui Hu, Neil Wei, Changqi Zhu, Michael B. O’Connor, Pavlos Pissios, Norbert Perrimon. Midgut-Derived Activin Regulates Glucagon-like Action in the Fat Body and Glycemic Control. Cell Metabolism 2017; 25(2) doi: 10.1016/j.cmet.2017.01.002
|
| 14 |
Ruochen Du, Liqi Wen, Min Niu, Liting Zhao, Xiaoya Guan, Jiao Yang, Chunming Zhang, Hongliang Liu. Activin receptors in human cancer: Functions, mechanisms, and potential clinical applications. Biochemical Pharmacology 2024; 222 doi: 10.1016/j.bcp.2024.116061
|
| 15 |
Hongjun Zhang, Baoling Ju, Xiaoli Zhang, Yanfei Zhu, Ying Nie, Yuanhong Xu, Qiuxia Lei. Magnolol Attenuates Concanavalin A‐induced Hepatic Fibrosis, Inhibits CD4+ T Helper 17 (Th17) Cell Differentiation and Suppresses Hepatic Stellate Cell Activation: Blockade of Smad3/Smad4 Signalling. Basic & Clinical Pharmacology & Toxicology 2017; 120(6) doi: 10.1111/bcpt.12749
|
| 16 |
Michele Vacca, Jack Leslie, Samuel Virtue, Brian Y. H. Lam, Olivier Govaere, Dina Tiniakos, Sophie Snow, Susan Davies, Kasparas Petkevicius, Zhen Tong, Vivian Peirce, Mette Juul Nielsen, Zsuzsanna Ament, Wei Li, Tomasz Kostrzewski, Diana Julie Leeming, Vlad Ratziu, Michael E. D. Allison, Quentin M. Anstee, Julian L. Griffin, Fiona Oakley, Antonio Vidal-Puig. Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis. Nature Metabolism 2020; 2(6) doi: 10.1038/s42255-020-0214-9
|
| 17 |
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman. Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma. Journal of Cellular Biochemistry 2022; 123(10) doi: 10.1002/jcb.30252
|
| 18 |
Matthew Hamang, Benjamin Yaden, Guoli Dai. Gastrointestinal pharmacology activins in liver health and disease. Biochemical Pharmacology 2023; 214 doi: 10.1016/j.bcp.2023.115668
|
| 19 |
Petra Džepina, Marijana Ćorić, Matea Kovačić Perica, Mirna Natalija Aničić, Ruža Grizelj, Jurica Vuković. Expression of activin A in liver tissue and the outcome of patients with biliary atresia. Frontiers in Pediatrics 2024; 12 doi: 10.3389/fped.2024.1457837
|
| 20 |
Dimitry A. Chistiakov, Pavel A. Chistiakov. Strategies to produce hepatocytes and hepatocyte‐like cells from pluripotent stem cells. Hepatology Research 2012; 42(2) doi: 10.1111/j.1872-034X.2011.00896.x
|
| 21 |
Olga K. Parfenova, Vladimir G. Kukes, Dmitry V. Grishin. Follistatin-Like Proteins: Structure, Functions and Biomedical Importance. Biomedicines 2021; 9(8) doi: 10.3390/biomedicines9080999
|
| 22 |
Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar, Limin Chen. Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated‐Interferon‐α Based Therapy. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/287640
|
| 23 |
Salima Aroua, Gersende Maugars, Shan-Ru Jeng, Ching-Fong Chang, Finn-Arne Weltzien, Karine Rousseau, Sylvie Dufour. Pituitary gonadotropins FSH and LH are oppositely regulated by the activin/follistatin system in a basal teleost, the eel. General and Comparative Endocrinology 2012; 175(1) doi: 10.1016/j.ygcen.2011.10.002
|
| 24 |
Blanca Herrera, Annalisa Addante, Aránzazu Sánchez. BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration. International Journal of Molecular Sciences 2017; 19(1) doi: 10.3390/ijms19010039
|
| 25 |
Xiao-Wei Zhang, Ji-Chao Zhou, Dian Peng, Fang Hua, Ke Li, Jiao-Jiao Yu, Xiao-Xi Lv, Bing Cui, Shan-Shan Liu, Jin-Mei Yu, Feng Wang, Cai-Cai Jin, Zhao-Na Yang, Chen-Xi Zhao, Xue-Ying Hou, Bo Huang, Zhuo-Wei Hu. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation. Autophagy 2020; 16(5) doi: 10.1080/15548627.2019.1635383
|
| 26 |
Roohi Chaudhary, Ralf Weiskirchen, Marcelo Ehrlich, Yoav I. Henis. Dual signaling pathways of TGF-β superfamily cytokines in hepatocytes: balancing liver homeostasis and disease progression. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1580500
|
| 27 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; doi: 10.1007/978-3-319-26587-2_172-1
|
| 28 |
Aristeidis H. Katsanos, Kalliroi Kyriakidi, Fotini B. Karassa, Dimitrios Politis, Alexandros Skamnelos, Dimitrios K. Christodoulou, Konstantinos H. Katsanos. Biomarkers for Endometriosis. 2017; doi: 10.1007/978-3-319-59856-7_3
|
| 29 |
Dongshunyi Li, Jeremy J. Velazquez, Jun Ding, Joshua Hislop, Mo R. Ebrahimkhani, Ziv Bar-Joseph. TraSig: inferring cell-cell interactions from pseudotime ordering of scRNA-Seq data. Genome Biology 2022; 23(1) doi: 10.1186/s13059-022-02629-7
|
| 30 |
Wenyi Tang, Zhilin Gu, Jiuqi Guo, Mingzhi Lin, Hongqian Tao, Dalin Jia, Pengyu Jia. Activins and Inhibins in Cardiovascular Pathophysiology. Biomolecules 2024; 14(11) doi: 10.3390/biom14111462
|
| 31 |
Kanghyug Choi, Hee Yoon Jang, Joong Mo Ahn, Sung Ho Hwang, Jung Wha Chung, Yun Suk Choi, Jin-Wook Kim, Eun Sun Jang, Gwang Hyeon Choi, Sook-Hyang Jeong. The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma. Clinical and Molecular Hepatology 2020; 26(4) doi: 10.3350/cmh.2020.0005
|
| 32 |
Pei-Wen Wang, Tung-Yi Lin, Pei-Ming Yang, Chau-Ting Yeh, Tai-Long Pan. Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022; 23(18) doi: 10.3390/ijms231810777
|
| 33 |
Bassem Refaat, Adel Galal El-Shemi, Ahmed Mohamed Ashshi, Adnan AlZanbagi. Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary Report. Gastroenterology Research and Practice 2014; 2014 doi: 10.1155/2014/628683
|
| 34 |
Emine Sahin, Julia Münzker, Michael Grusch. Encyclopedia of Cancer. 2014; doi: 10.1007/978-3-642-27841-9_7169-9
|
| 35 |
Deng-Yong Zhang, Jia-Sheng Lei, Wan-Liang Sun, Dong-Dong Wang, Zheng Lu. Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma. Chinese Medical Journal 2020; 133(15) doi: 10.1097/CM9.0000000000000847
|
| 36 |
Hidekazu Ooe, Qijie Chen, Junko Kon, Kazunori Sasaki, Hiroyuki Miyoshi, Norihisa Ichinohe, Naoki Tanimizu, Toshihiro Mitaka. Proliferation of rat small hepatocytes requires follistatin expression. Journal of Cellular Physiology 2012; 227(6) doi: 10.1002/jcp.22971
|
| 37 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; doi: 10.1007/978-3-319-26956-6_172
|
| 38 |
Grigorios Panagiotou, Wael Ghaly, Jagriti Upadhyay, Kalliopi Pazaitou-Panayiotou, Christos S Mantzoros. Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans. The Journal of Clinical Endocrinology & Metabolism 2021; 106(5) doi: 10.1210/clinem/dgab041
|